All Blogs

Mar 18, 2024

Promising Nephrotic Syndrome Treatments: A Look into the Future


Mar 15, 2024

Unveiling the Potential of TROP-2 Inhibitors: A New Frontier in Cancer Treatment


Mar 14, 2024

Allumiqs and Prolytix’s Partnership; Setpoint Medical’s Neuroimmune Modulation Platform gets FDA Breakthrough Designation; MangoRx Launches ‘PRIME’ with FDA-approved TRT; SeaStar Medical Updates Quelimmune Commercial Launch; Ventris Medical Gains 510(k) for Amplify® Bone Graft Putty


Mar 13, 2024

Telemedicine Service: Delving into Opportunities and Key Growth Factors Driving Market


Mar 12, 2024

BeiGene’s BRUKINSA Gets FDA Accelerated Approval; GSK’s Positive Results in DREAMM-8 Phase III; Sandoz’s Denosumab Biosimilars FDA Approved; Terns Pharma’s TERN-701 Receives Orphan Drug Designation; Wegovy® Approved in US for Overweight Cardiovascular Risk; Travere Therapeutics Submits sNDA for FILSPARI IgAN Full Approval


Mar 11, 2024

Giant-Cell Arteritis Treatment Beyond Glucocorticoids: Exploring Horizons


Mar 08, 2024

Breakthroughs in Alport Syndrome Treatment: A New Era of Hope


Mar 07, 2024

Philips Teamed with SyntheticMR; BioPhotas’s Celluma Light Therapy; Boston Scientific’s AGENTTM Drug-Coated Balloon; Varian’s TrueBeam and Edge Radiotherapy Systems; Carthera’s Brain-Blood Barrier Trial; Prototype Device Effectively Treated Multiorgan Failure


Mar 06, 2024

How Innovations Are Driving the Growth of the Nicotine Replacement Therapy Market?


Mar 06, 2024

Major Highlights and Insights from the AAAAI Annual Meeting, 2024